Lig3 has been ascribed repair functions during DNA replication, DNA strand break repair via the BER/single-strand break repair pathway, and has been implicated in double-strand break repair if non-homologous end-joining is disabled[@R1],[@R7]--[@R9]. Given the close association between Xrcc1 and Lig3 and the substantial DNA repair deficiency present when Xrcc1 is inactivated, the link between Lig3 and DNA repair is compelling[@R1]--[@R3],[@R7],[@R8].

In the mitochondria Lig3 functions during replication and repair of mtDNA, but in an Xrcc1-independent manner[@R4],[@R10]--[@R12]. The highly oxidative environment of the mitochondria suggests that DNA repair will be important for mtDNA maintenance[@R11]--[@R17], particularly as mtDNA point mutations or deletions can result in mitochondrial dysfunction[@R13],[@R18]--[@R20]. Defects in mtDNA maintenance are the bases of multiple human syndromes. For example, distinct mutations of DNA polymerase gamma (PolG), a mitochondrial-specific polymerase that is essential for mtDNA replication, can result in diverse human syndromes involving ataxia, Parkinsonism or diabetes[@R20]--[@R24]. Consequently, Lig3 is potentially critical for both nuclear and mtDNA integrity.

In order to determine the biological role of Lig3, we generated *Lig3^Nes-cre^* mice, in which *Lig3* was conditionally inactivated throughout the nervous system using *Nestin-cre*. While germline *Lig3* deletion is lethal early during embryonic development[@R5], *Lig3^Nes-cre^* mice were born alive. Although initially indistinguishable from wild type (WT) littermates, *Lig3^Nes-cre^* mice became growth retarded and profoundly ataxic by two weeks of age (Suppl. Movie 1), and didn't survive beyond 20 days of age ([Suppl. Fig. 1](#SD1){ref-type="supplementary-material"}). Magnetic resonance imaging of postnatal day 14 (P14) *Lig3^Nes-cre^* mice revealed a smaller brain compared with controls ([Fig. 1a](#F1){ref-type="fig"}). *Lig3^Nes-cre^* tissue had markedly reduced Lig3 levels in the brain, but not elsewhere ([Fig. 1b](#F1){ref-type="fig"}), and despite Lig3 instability after Xrcc1 loss[@R2],[@R6], the converse did not occur ([Fig. 1b](#F1){ref-type="fig"}). In contrast to WT and *Xrcc1^Nes-cre^*, the *Lig3^Nes-cre^* cerebellum was substantially smaller, showing both reduced proliferation and increased apoptosis of granule neuron progenitors, resulting in widespread loss of these cells ([Fig. 1d](#F1){ref-type="fig"} and [Suppl. Fig. 2](#SD1){ref-type="supplementary-material"}). Other cell types such as oligodendrocytes were also affected in the *Lig3^Nes-cre^* brain ([Suppl. Fig. 3](#SD1){ref-type="supplementary-material"}).

Given that Xrcc1 stabilizes Lig3, we determined if Lig3 loss also disrupts cerebellar interneurons, a hallmark phenotype after Xrcc1 inactivation[@R6]. However, the *Lig3^Nes-cre^* cerebellum contained a normal complement of interneurons as determined by Western blot of cerebellar extracts and tissue immunostaining using anti-Pax2, a marker for this neuronal type ([Fig. 1e,f](#F1){ref-type="fig"}). Therefore, despite their close association, inactivation of Lig3 leads to a strikingly different neural phenotype to Xrcc1 loss.

As *Xrcc1^Nes-cre^* and *Lig3^Nes-cre^* are phenotypically distinct, and because Lig3 inactivation can compromise mtDNA[@R11], we determined if the *Lig3^Nes-cre^* neurodevelopmental defects were due to disruption of mitochondrial function. Using mitotracker to label mitochondria, we found a pronounced mitochondrial defect in primary *Lig3^Nes-cre^* cortical astrocytes ([Fig. 2a](#F2){ref-type="fig"}). In both WT and *Xrcc1^Nes-cre^* astrocytes there was an elaborate distribution of actively streaming mitochondria. In stark contrast, mitochondria in *Lig3^Nes-cre^* astrocytes were static and showed an abnormal morphology and distribution ([Fig. 2a](#F2){ref-type="fig"} and Suppl. Movie 2).

Identification of mtDNA using pico-green showed a normal distribution in WT or *Xrcc1^Nes-cre^* cells (arrows), but an absence of mtDNA in *Lig3^Nes-cre^* astrocytes ([Fig. 2a](#F2){ref-type="fig"}). We then assessed mtDNA integrity *in vivo* in the *Lig3^Nes-cre^* brain and found the amount of recovered mtDNA from this tissue was markedly decreased compared with that from equal amounts of WT tissue or *Lig3^Nes-cre^* liver ([Fig. 2b](#F2){ref-type="fig"}). This was further confirmed using a PCR assay that amplified specific mtDNA regions, which showed a loss of mtDNA throughout the *Lig3^Nes-cre^* brain ([Fig. 2b](#F2){ref-type="fig"}). *Lig3^Nes-cre^* astrocyte cultures also became acidic compared to WT cultures, suggesting lactic acid accumulation because of defective oxidative respiration, and accordingly, *Lig3^Nes-cre^* cells were defective in oxygen metabolism ([Suppl. Fig. 4](#SD1){ref-type="supplementary-material"}).

We then directly assessed mitochondria ultrastructure in the *Lig3^Nes-cre^* brain using electron microscopy. We found morphological abnormalities of the mitochondria at postnatal times coinciding with the emergence of ataxia. By P7, cerebellar Purkinje neurons showed mitochondria with distorted cristae structure and broad changes in mitochondrial morphology ([Fig. 2c](#F2){ref-type="fig"}).

We also assessed components of the mtDNA-encoded electron transport chain, which are often affected in dysfunctional mitochondria[@R22]. By P5, there was a marked reduction of complex III (CO III), and COX IV immunostaining in Purkinje cells ([Fig. 2d](#F2){ref-type="fig"}), and elsewhere throughout the brain including hippocampal structures and the cortices ([Suppl. Fig. 5](#SD1){ref-type="supplementary-material"}). The biochemical activity of complex I was also reduced in *Lig3^Nes-cre^* brain ([Suppl. Fig. 5](#SD1){ref-type="supplementary-material"}). Consistent with increased free radical production from dysfunctional mitochondria increased tyrosine nitrosylation was found in the *Lig3^Nes-cre^* brains ([Suppl. Fig. 6](#SD1){ref-type="supplementary-material"}).

We also generated *Lig3^Ckmm-cre^* mice, in which the muscle creatine kinase promoter drives cre-mediated deletion of *Lig3*, and confirmed diminished Lig3 levels in cardiac and skeletal muscle, while levels in the brain were normal ([Fig. 3a](#F3){ref-type="fig"}). All *Lig3^Ckmm-cre^* mice died abruptly between 3.5 to 4.5 weeks of age ([Fig. 3b](#F3){ref-type="fig"}). Although we did not find any histological difference between Lig3 mutant and wild type skeletal muscle, *Lig3^Ckmm-cre^* mice showed heart defects associated with cardiac Lig3 inactivation. Overall heart size of the mutants was larger than controls, and dilation of the ventricle and atrium and thinning of the ventricle walls was apparent ([Suppl. Fig. 7](#SD1){ref-type="supplementary-material"}). We also identified disruption in connexin-43, depletion of cardiac troponin-I and defective intercalated disc structure, suggesting that force generation and transmission during cardiac muscle contraction is defective ([Fig. 3c](#F3){ref-type="fig"} and [Suppl. Fig. 7](#SD1){ref-type="supplementary-material"}). Electron microscopy of mutant heart muscle also revealed disruption of myofiber structure and pronounced defects in mitochondrial morphology ([Fig. 3d](#F3){ref-type="fig"} and [Suppl. Fig. 7](#SD1){ref-type="supplementary-material"}).

We monitored heart function using transthoracic ultrasound echocardiography (ECG) in *Lig3^Ckmm-cre^* and WT animals beginning from 3 weeks of age. M-mode echocardiography showed that the diastolic and systolic movement of the left ventricle wall and interventricular septum was decreased in *Lig3^Ckmm-cre^* mice, which was associated with an ECG reading reflecting an abnormal heart rhythm ([Fig. 3e](#F3){ref-type="fig"}). Fractional shortening and ejection fraction ([Fig. 3f](#F3){ref-type="fig"}), two ways of measuring cardiac contractility, were also decreased significantly in *Lig3^Ckmm-cre^* mice, indicating heart pump function was severely affected, a phenomenon often leading to heart failure.

Although Lig3 is linked to DNA repair via interaction with and stabilization by Xrcc1[@R2],[@R6], the role for this ligase during nuclear DNA repair is unclear. Therefore, we initially compared nuclear DNA repair in WT, *Lig3^Nes-cre^* and *Xrcc1^Nes-cre^* astrocytes after treatment with various genotoxins. We found that DNA repair after H~2~O~2~ and ionizing radiation (IR) in quiescent *Lig3^Nes-cre^* astrocytes was similar to WT cells while *Xrcc1^Nes-cre^* cells showed a marked repair defect ([Fig. 4a,b](#F4){ref-type="fig"}). One exception was UV damage, where DNA repair in *Lig3^Nes-cre^* cells was reduced compared to controls; although, even in this situation *Xrcc1^Nes-cre^* cells showed a substantially greater DNA repair defect ([Suppl. Fig. 8](#SD1){ref-type="supplementary-material"}). This may indicate that Lig3 is selectively required to repair specific types of DNA lesions[@R25].

As Lig3 loss did not substantially impact DNA repair after H~2~O~2~ or IR, we considered if a sub-pathway of BER, termed long-patch-repair (LPR)[@R7] might functionally compensate for defects in short patch BER. This is the situation when another repair factor, Aprataxin (Aptx) is defective[@R26]. We used aphidicolin to acutely inhibit the LPR polymerases Polδ and Polε, but found no DNA repair defect in *Lig3^Nes-cre^* cells after methylmethane sulphonate (MMS) ([Suppl. Fig. 8](#SD1){ref-type="supplementary-material"}). In contrast to *Lig3^Nes-cre^* cells, quiescent *Aptx^−/−^* astrocytes had a reduced rate of DNA repair after MMS in the presence of aphidicolin, indicating LPR inhibition ([Fig. 4d](#F4){ref-type="fig"}).

To further determine repair capability and potential functional compensation by other DNA ligases in the absence of Lig3, we used lentiviral-mediated shRNA in primary MEFs to inactivate Lig1, Lig3 and Lig4 ([Fig. 4c](#F4){ref-type="fig"}). Importantly, under the conditions we established for shRNA-mediated ligase knockdown, minimal cell lethality was observed (not shown). Using this approach, we found that similar to *Lig3^Nes-cre^* cells, Lig3-depleted cells were also competent to repair H~2~O~2~-induced DNA damage in quiescent cells ([Fig. 4d](#F4){ref-type="fig"}). In contrast, inactivation of Lig1, but not Lig4, resulted in a marked defect in the ability to repair H~2~O~2~-induced DNA damage ([Fig. 4d](#F4){ref-type="fig"}). Moreover, dual inactivation of Lig1 and Lig3 resulted in an exacerbated repair deficiency that was similar to *Tdp1^−/−^* cells, indicating functional cooperation between Lig1 and Lig3 after H~2~O~2~ treatment ([Fig. 4d,e](#F4){ref-type="fig"}). We then compared other genotoxins including IR and MMS and found that similar to damage induced by H~2~O~2~, individual loss of Lig1 but not Lig3, strongly affected DNA repair ([Fig. 4f](#F4){ref-type="fig"} and [Suppl. Fig. 8](#SD1){ref-type="supplementary-material"}). In the case of IR, where both DNA single- and double-strand breaks occur, Lig4 inactivation also markedly reduced repair. Again, a cooperative defect was found after dual inactivation of Lig1 and Lig3 during repair of IR-induced lesions. The DNA repair defect associated with Lig1 inactivation was specific, as a modified Lig1 cDNA that was shRNA-resistant (Lig1^shR^) restored repair capacity of the shLig1-targeted cells after H~2~O~2~ and MMS ([Fig. 4g](#F4){ref-type="fig"} and [Suppl. Fig. 8](#SD1){ref-type="supplementary-material"}).

While Xrcc1-mediated stabilization of Lig3 in the nucleus suggests Lig3 is important during DNA repair[@R2],[@R7],[@R8], our data show that Lig3 is generally dispensable for Xrcc1-mediated DNA repair. On the other hand, our data show that Lig1 is clearly the operative ligase that repairs DNA lesions in quiescent cells usually ascribed to Lig3. However, it is likely that the repair of specific subsets of DNA lesions do involve Lig3 given the increased repair deficiency after coordinate inactivation of Lig1 and Lig3. While some controversy exists over the role of Lig1 during DNA repair[@R27],[@R28], our data clearly identify Lig1 as a key player in this process. Increased sensitivity of repair assays may aid in further delineating Lig3 function during nuclear DNA repair.

The mitochondrial defects associated with Lig3 inactivation could occur at the level of mtDNA replication and/or repair. Generation of a mouse with a defect in the proof-reading function of PolG lead to accumulation of mtDNA mutations[@R20]. However, while these animals were viable they showed a variety of age-related defects associated with mtDNA mutations, and many survived greater than a year without developing the phenotypes we found after Lig3 inactivation in the brain or heart. In contrast, mitochondrial transcription Factor A is essential for mtDNA replication, and its inactivation in the heart using *Ckmm-cre*[@R29] produced a similar phenotype to the *Lig3^Ckmm-cre^* mice, suggesting defective mtDNA replication underpins the Lig3 mutant phenotype.

Although the Lig3-deficient nervous system (and heart) develops in a relatively normal manner, we assume mtDNA is nonetheless compromised during development of these tissues. The pronounced decline in the newborn *Lig3^Nes-cre^* brain (and *Lig3^Ckmm-cre^* heart) may be a combination of mtDNA defects acquired during organogenesis and stresses associated with the physiological and respiratory changes at birth[@R30], and the high demand for oxidative metabolism.

Thus, our data point to disparate biological roles for Lig3 and Xrcc1, with each primarily important in separate cellular compartments to ensure the integrity of mitochondrial and nuclear DNA, respectively. Additional analyses of Lig3 function during nuclear DNA repair and mtDNA maintenance will provide important insights into genome stability, mitochondrial biology and tissue homeostasis. Lig3 mutations may also underpin some of the many mitochondrial diseases for which the causative gene defect is unknown.

Methods Summary {#S1}
===============

Generation of Lig3 mutant mice {#S2}
------------------------------

Embryonic stem cells were electroporated with a targeting vector incorporating *LoxP* sites flanking exons 6--14 of Lig3 to obtain mice with a floxed *Lig3* allele. Intercrossing these with *Nes-cre* or *Ckmm-cre* mice generated *Lig3^Nes-cre^* or *Lig3^Ckmm-cre^* animals.

Mitochondrial analysis {#S3}
----------------------

MitoTracker Red and Picogreen were used to label astrocyte mitochondria. For EM, tissues were paraformaldehyde-fixed with osmium tetroxide post-fixing, and stained with uranyl acetate. mtDNA was assessed using pulsed field gel electrophoresis and PCR.

Cardiac analysis {#S4}
----------------

A VEVO-770 instrument (VisualSonics, Toronto, Canada) was used for echocardiography analysis. ECG was determined and M-mode analysis was done to measure cardiac contractility.

DNA repair analysis {#S5}
-------------------

*Lig3^Nes-cre^, Xrcc1^Nes-cre^*, *Aptx^−/−^* and control astrocytes were prepared as described previously[@R6]. MEFs were established from E13.5 embryos. RNA interference was used to inactivate DNA ligases in primary MEFs. ShRNA-encoding lentiviral particles were produced via co-expression of pLKO.1-puro plasmids (TRC1, Sigma) with Mission Lentiviral packaging DNA (Sigma, SHP001) in 293T cells. The Comet Assay IV system (Perceptive Instruments) was used to assay DNA damage as described[@R6],[@R26].

Full Methods {#S6}
============

Ligase 3 mice {#S7}
-------------

A targeting vector was designed to conditionally delete exons 6--14 using recombineering. A single *LoxP* site was inserted between exons 14 and 15 and a neomycin-thymidine kinase selection cassette flanked by *Frt* sites with a single *LoxP* site was inserted between exons 5 and 6. The targeting construct was transfected into embryonic stem (ES) cells via electroporation and selection with G418, homologous recombinants were screened by Southern blotting using both 3' and 5' probes outside the targeted region. Positive clones were transfected a second time with a Flt recombinase expressing vector. Cells were selected using FIAU to remove cells retaining the thymidine kinase and further screened by PCR using primers flanking the *LoxP* site or the *LoxP*/*Frt* remaining after recombination. Positive clones were blastocyst-injected to generate chimeric mice. The male chimeras were bred with C57BL/6 females to establish mice carrying the conditional *Lig3* allele. Further breeding with cre mice under the control of the Nestin promoter (JAX\#003771: B6.Cg-Tg(Nes-cre)1Kln/J) resulted in deletion throughout the nervous system, while breeding with the Ckmm2-cre mice (JAX\#006475: B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J) deleted Ligase 3 in skeletal and cardiac muscle.

Histology {#S8}
---------

Mice were perfused with 4% (w/v) buffered paraformaldehyde and cryoprotected in buffered 25% sucrose (w/v) solution. Brains were dissected, cut sagittally and sectioned at 10µm using an HM500M cryostat (Microm). Nissl staining was carried out with 1% (w/v) thionin. Hematoxylin and eosin staining was done according to standard procedures. Immunohistochemical and immunocytochemical staining of tissues and cells were carried out with the antibodies listed below. For colorimetric visualization of positive signals, sections were incubated with antibodies overnight at room temperature after quenching endogenous peroxidase using 0.6% (v/v) H~2~O~2~ in methanol. Slides were washed with phosphate-buffered saline (PBS) three times, followed by incubation with biotinylated secondary antibody and avidin-biotin complex (Vectastain Elite kit, Vector Labs). Antibodies were used after citrate buffer--based antigen retrieval. Immunoreactivity was visualized with the VIP substrate kit (Vector Labs) using the manufacturer\'s protocol. After staining, sections were counterstained with 0.1% (w/v) methyl green, dehydrated, and mounted in DPX (Fluka). For fluorescent signals of immunoreactivity, FITC- or Cy3-conjugated secondary antibodies (Jackson Immunologicals) were used and counterstained with 4\'6-diamidino-2-phenylindole (DAPI) or propidium iodide (Vector Laboratories). For immunohistochemistry and immunocytochemistry, we used the following antibodies: calbindin (mouse, 1:2,000, Sigma), PCNA (mouse, 1:500, Santa Cruz Biotechnology), Pax2 (rabbit, 1:500, Zymed \#71--6000), CO III-core 2 (mouse, 1:2000, MitoSciences), Ki67 (rabbit, 1:250, Vector Laboratories), COX IV (mouse, 1:500, Abcam), cardiac Troponin-I (mouse, 1:50 fluorescence and 1:500 Western blots, Abcam) and connexin-43 (rabbit, 1:50, Cell Signaling). Apoptosis was detected using the TUNEL assay with the Apoptag kit (Chemicon) according to the manufacturer\'s protocol.

Western blot analysis {#S9}
---------------------

Western blot analysis was performed with tissues (cortex, cerebella, liver and spleen) from both P5 control mice (*Lig3^LoxP/+^;Nes-cre*) and conditional knockout mice (*Lig3^LoxP/LoxP^;Nes-cre*). Protein extracts were prepared by using lysis buffer (50mM Tris-HCl, 200mM NaCl, 0.2% NP-40, 1% Tween-20 (v/v), 1mM NaF, 1mM sodium vanadate, 50mM β-glycerophosphate, 2mM PMSF, and Complete protease inhibitor (Roche) and quantified by Bradford assay (Bio-Rad). Proteins (50µg per lane) were separated through a 4--12% (w/v) Bis-Tris SDS polyacrylamide gel (Invitrogen) and transferred onto nitrocellulose membrane (Bio-Rad). Blots were sequentially immunostained with mouse anti-Lig3 antibody (1:500, BD Biosciences) followed by horseradish peroxidase--conjugated donkey anti-mouse (1:2,000, GE Healthcare) and detected using ECL Plus chemiluminescence reagent (GE Healthcare). To detect XRCC1 protein levels, the immunoblots were stained with rabbit anti-Xrcc1 antibody[@R6] (1:1000) and processed as described above. Immunoblots were also stained with mouse complex V subunit-α antibody (mouse, 1:1000, Mitoscience) and Pax2 (1/5000, Abcam \#79389) and processed as described above. Actin antibody (1:1,000, Santa Cruz Biotech) was used as a protein-loading control.

Mitochondrial analysis {#S10}
----------------------

For mitochondria staining, primary astrocytes were incubated with prewarmed (37°C) culture medium described below containing MitoTracker Red (1:200, Invitrogen) for one hour under normal growth conditions followed by media replacement for an additional 20mins. For mtDNA staining, the astrocytes were incubated with prewarmed culture medium containing Picogreen (3µl/ml, Invitrogen) for one hour under normal growth conditions. Cells were imaged and processed using a Nikon C1Si confocal microscope and EZCi imaging software (Nikon USA, Melville, N.Y.) using a 561 DPSS laser (Melles Griot, Albuquerque, NM). Complex I activity assays were done with brain samples using a MitoSciences microplate assay kit ([www.mitosciences.com](http://www.mitosciences.com)) according to the manufacturers directions. Cellular oxygen consumption was measured using an Oxygen Biosensor system 96-well plate (BD) according to the manufacturer's directions.

Mitochondria were isolated from brain tissue using the Qproteome™ Mitochondria Isolation Kit, (QIAGEN) according to the manufacturer's directions, and mtDNA was isolated using the Mitochondrial DNA Isolation Kit (BioVision) according to the manufacturer's directions. PCR of mtDNA was done using the Expand Long Range, dNTPack (Roche) with the following conditions: Initial denaturation at 92°C for 30sec followed by annealing at 56°C for 30sec and elongation at 68°C (at 60s/kb) for 39 cycles, with a final 68oC elongation for 10mins. Primers used: 'Set A', forward, 5'-CCT TCA TCC TTC TCT CCC TAT GAG GA, reverse 5'-GGT TGT TTG ATC CTG TTT CGT GGA and 'Set B', forward, 5'-CCC AGC TAC TAC CAT CAT TCA AGT, reverse 5'-CAG TAT GCT TAC CTT GTT ACG ACT.

Mitochondrial DNA isolated from equal amounts of *Lig3* mutant or control tissue were lysed in 1mg/ml proteinase K, 1% (w/v) N-lauroylsarcosine, (pH9.5) in LM-agarose plugs overnight and subjected to pulsed field gel electrophoresis. Mitochondrial DNA was separated for 24 hours with gradual changes in pulses from 0.05 to 20secs at 3.0V/cm at an angle of 120° in 1% megabase agarose gel (Bio-Rad) with the CHEF Mapper Pulsed Field Electrophoresis system (Bio-Rad). DNA was visualized with ethidium bromide or Southern blot analysis using radioactive mtDNA as a probe.

Isolation of primary cells {#S11}
--------------------------

Primary astrocytes were prepared from P2 mouse brains as described previously[@R6]. Cortices were dissociated by passage through a 5ml pipette and cells were resuspended in Dulbecco\'s modified Eagle\'s medium and Ham\'s nutrient mixture F-12 (1:1 DMEM/F12, Gibco-BRL) supplemented with 10% fetal bovine serum (v/v), 1× glutamax, 100U/ml penicillin, 100µg/ml streptomycin and 20ng/ml epidermal growth factor (Millipore). Primary astrocytes were established in Primeria T-25 tissue culture flasks (Falcon) at 37°C in a humidified CO~2~-regulated (5%) incubator.

Primary mouse embryonic fibroblasts (MEFs) were prepared from E13.5 embryos. Embryos were minced using dissection scissors, passed through a 23 gauge syringe followed by a 70 µm cell strainer. Cells were resuspended in Dulbecco\'s modified Eagle\'s medium supplemented with 10% fetal bovine serum (v/v), 1× glutamax, 100 U/ml penicillin, 100 µg/ml streptomycin and β-mercaptoethanol and established in T-25 tissue culture flasks (Falcon) at 37°C in a humidified CO~2~-regulated (5%) incubator.

Magnetic resonance imaging {#S12}
--------------------------

Two week-old mutant and control mice (age and sex matched) were subjected to magnetic resonance imaging analysis. All animals were scanned on a 7 Tesla Bruker Clinscan animal magnetic resonance imaging scanner (Bruker BioSpin MRI GmbH) as described previously[@R6].

Electron microscopy {#S13}
-------------------

Mice were perfused with 4% paraformaldehyde, 100mM cacodylate, 2.5% sucrose, (pH 7.4), and fixed overnight. Samples were post fixed in osmium tetroxide, stained in 2% uranyl acetate, dehydrated, and embedded in Epon Beem Capsules. 80 nm *en face* sections were prepared on a Leica UCT ultramicrotome and collected onto 200 mesh copper grids. Images were collected on JoeL JEM-1200 EXII TEM equipped with AMTV600 digital camera.

DNA repair analysis {#S14}
-------------------

Quiescent primary astrocytes or MEFs (2×10^5^ cells/ml/sample) were treated with either 150µM H~2~O~2~ for 10 min on ice, methylmethane sulphonate (MMS) for 10min at various concentrations at 37°C or γ--irradiation (either 10 or 20Gy, Cs^137^). Following H~2~O~2~ and IR treatments, cells were incubated for various times in drug-free medium at 37°C. Cells were trypsinized and suspended in pre-chilled 1× PBS, mixed with an equal volume of 1.2% low-melting point agarose (Invitrogen) maintained at 42°C and immediately layered onto frosted glass slides (Fisher) pre-coated with 0.6% agarose and maintained in the dark at 4°C for all further steps. Slides were immersed in pre-chilled lysis buffer (2.5 M NaCl, 10mM Tris-HCl, 100 mM EDTA (pH 8.0), 1% (v/v) Triton X-100, 3% (v/v) DMSO, pH10) for 1 h, washed with pre-chilled distilled water (twice for 10 min each) and placed into pre-chilled alkaline electrophoresis buffer (50 mM NaOH, 1mM EDTA, 1% DMSO) for 45 min. Electrophoresis was carried out at 95mA (astrocytes) or 190 mA (MEFs) for 25 min, followed by neutralization in 0.4 M Tris-HCl (pH 7.0). Comets were stained with SYBR Green (1:10,000 in 1× PBS, Sigma) for 10 min. A minimum of 100 comet tail moments were measured using the Comet Assay IV system (Perceptive Instruments) coupled to an Axioskop2 plus microscope (Zeiss) at 200× magnification.

Lentivirus particles were used to deliver and express shRNAs to knock down murine ligases 1, 3 and 4, with Nbs1 and a non-target scrambled shRNA used as controls. All MISSION^®^ shRNA plasmid DNA constructs were obtained from SIGMA-ALDRICH (St Louis, MO). The pLKO.1-puro parental vector expressed the TRC1 shRNAs and included: shLig1--5'-CCG GGC CCG GAC ATT TGA GAA GAT TCT CGA GAA TCT TCT CAA ATG TCC GGG CTT TTT G, shLig3--5'-CCG GCC ACC GAA CAG AAG CTC AAT ACT CGA GTA TTG AGC TTC TGT TCG GTG GTT TTT G and shLig4--5'-CCG GCC TCT CAG TAT GTT TCG ACA TCT CGA GAT GTC GAA ACA TAC TGA GAG GTT TTT G.

Lentivirus was made via co-transfection of pLKO.1-puro plasmids with Mission Lentiviral packaging DNA (Sigma, SHP001) into subconfluent 293T cells using Fugene 6 (Roche). Lentivirus was collected 48 hours later and filtered (0.45µm pore size) and primary MEFs (1.25 × 10^5^ cells in 6cm^2^ plates grown for 20 hrs) were transduced with individual or a combination of lentiviral particles for 36 hours at 37°C with polybrene (10 µg/ml). All data reflects experiments performed in triplicate. Western blots were used to confirm shRNA knockdowns; antibodies used were Nbs1 (1/500, Cell Signaling), Lig1 (1/1000, Santa Cruz Biotech), Lig3 (1/500, BD Biosciences) and Lig4 (1/400, Abcam).

Generation of an shLig1-resistant Lig1 cDNA (Lig1^shR^) was done using the following primers: L1^shR^forward-5'-CTT ACC TGG CTG TGG CAA GCA CGT TCG AGA AAA TCG AGG AGG TGT CTG C and L1^shR^reverse-5'-GCA GAC ACC TCC TCG ATT TTC TCG AAC GTG CTT GCC CAC GCC AGG TAA G. These silent mutations were introduced into human Lig1 cDNA using the Quikchange II Site-Directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions. The modified Lig1 construct was co-transfected into MEFs with pmaxGFP plasmid (4:1 ratio) using Nucleofector methodology (Lonza) and then FACS-sorted to select for GFP-positive cells (\~30%). Lig1^shR^transfected cells were then treated with shScr, shLig1 or a combination of shLig1/shLig3 lentivirus and assayed for DNA repair after genotoxic stress using the comet assay, as described above.
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![Lig3 inactivation throughout the nervous system leads to a phenotype different to Xrcc1 loss\
(a) MRI analysis of the *Lig3^Nes-cre^* nervous system shows microcephaly and a small cerebellum (arrow) compared to WT. (b) Lig3 is deleted in various *Lig3^Nes-cre^* brain regions while Xrcc1 protein levels are unaffected. (c) Comparative Nissl staining of P14 cerebellum (Ce) from *Lig3^Nes-cre^*, *Xrcc1^Nes-cre^* and WT. (d) PCNA immunostaining shows disrupted neurogenesis in the P6 *Lig3^Nes-cre^* cerebellum (arrows). (e) Levels of the interneuron marker Pax2 are similar in control and *Lig3^Nes-cre^* tissue, but substantially reduced in the *Xrcc1^Nes-cre^* cerebellum. (f) Interneurons are present in the *Lig3^Nes-cre^* cerebellum but are absent from *Xrcc1^Nes-cre^* tissue (arrows) as determined by Pax2 immunostaining.](nihms260486f1){#F1}

![Mitochondrial function is disrupted in the *Lig3^Nes-cre^* brain\
(a) Mitotracker labeling reveals defects in mitochondria from *Lig3^Nes-cre^* but not WT or *Xrcc1^Nes-cre^* astrocytes. Picogreen staining shows reduced mtDNA in *Lig3^Nes-cre^* astrocytes; N is the nucleus. Boxed areas show the region expanded in adjacent panels. (b) Analysis of mtDNA via pulse field gel electrophoresis shows an age-dependent quantitative reduction in mtDNA from P5-P14 *Lig3^Nes-cre^* brain compared with controls. mtDNA levels in the *Lig3^Nes-cre^* liver were similar to control tissue. PCR of mtDNA revealed a reduction in mtDNA isolated from *Lig3^Nes-cre^* brain tissue (asterisks). Ctx is cortex, Cereb is cerebellum and Di is diencephalon. (c) Electron microscopy showed alterations in mitochondrial morphology in Lig3-deficient Purkinje cells compared to WT tissue. (d) Electron transport chain components complex III core 2 (CO III) and COX IV staining *in vivo* is reduced in P7 cerebellar Purkinje cell mitochondria; counterstain is DAPI.](nihms260486f2){#F2}

![Lig3 inactivation causes cardiac failure associated with defective mitochondrial function\
(a) Lig3 protein levels are reduced in *Lig3^Ckmm-cre^* heart and skeletal muscle. A reduction of complex V subunit α also occurs in *Lig3^Ckmm-cre^* heart. (b) *Lig3^Ckmm-cre^* mice die between 3.5 and 4.5 weeks of age; n is the number of animals. (c) Altered connexin-43 distribution and depletion of cardiac troponin I occurs in 4-week-old *Lig3^Ckmm-cre^* heart. A Western blot shows decreased cardiac troponin I levels. (d) Electron microscopy of cardiac muscle shows disruption in myofiber structure and defects in mitochondrial morphology. (e) Echocardiographic analysis of *Lig3^Ckmm-cre^* mice shows movement of the interventricular septum (IVS) and the posterior walls of the left ventricle (LVPW) were decreased in the *Lig3^Ckmm-Cre^* heart (arrows). Traces below the echocardiogram show ECG readings indicate abnormal heart rhythm. (f) Cardiac contractility was also significantly depressed with decreased ejection fraction and fraction shortening indicating that the pump function of the *Lig3^Ckmm-Cre^* heart is defective. Three individual animals of each genotype were used; error bars represent standard deviation.](nihms260486f3){#F3}

![Lig3 is not essential for nuclear DNA repair\
(a) Alkaline comet analysis shows DNA strand break repair after hydrogen peroxide treatment is similar between WT and *Lig3^Nes-cre^* quiescent primary astrocytes, but is defective in *Xrcc1^Nes-cre^* cells, as is repair after ionizing radiation (b); R30/R60 is recovery from the genotoxin after 30 or 60 minutes. Assays were run in triplicate from at least three separate experiments; error bars in all panels represent standard error of the mean. (c) Western blot analysis indicates specific shRNA-mediated knockdown of mammalian DNA ligases. Non-target scrambled (Scr) and Nbs1 shRNAs were included as controls, and Ponceau staining indicates relative protein transfer. (d) Lig1 is required for DNA repair after H~2~O~2~ damage; dual inactivation of Lig1 and Lig3 reveals cooperation between these ligases during repair. *Tdp1^−/−^* MEFS are a repair-deficient control. Photograph indicates cells are quiescent based on p27^+^ and PCNA^−^ immunoreactivity. (e) Representative individual comet tail moments of shRNA-mediated knockdowns after H~2~O~2~ treatment. (f) Lig1 and Lig4 are required for DNA repair after IR. Lig1 and Lig3 cooperate in the repair of IR-induced DNA damage. (g) DNA repair competency after H~2~O~2~ treatment is restored using a shLig1-resistant version of Lig1 cDNA (Lig1^shR^).](nihms260486f4){#F4}
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